Baroldi Joseph — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Baroldi Joseph has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.29M.

Profile

Baroldi Joseph

Joseph Baroldi is the Executive Vice President and Chief Business Officer at Ionis Pharmaceuticals, a leader in antisense technology for drug development. He has been involved in various roles within the company, contributing to its focus on innovative treatments for a range of diseases.

RoleEVP, Chief Business Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-30IONSIONIS PHARMACEUTICALS INCS — Open-market sale5.6K$80.16$452K
2026-06-30IONSIONIS PHARMACEUTICALS INCM — Option exercise1.8K$32.60$58K
2026-06-30IONSIONIS PHARMACEUTICALS INCM — Option exercise3.9K$56.78$220K
2026-04-17IONSIONIS PHARMACEUTICALS INCS — Open-market sale5.6K$74.56$419K
2026-04-17IONSIONIS PHARMACEUTICALS INCM — Option exercise10.8K$0.00
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]201$80.00$16K
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]201$32.60$7K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]238$80.00$19K
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]238$56.78$14K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]36$81.01$3K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]2.1K$80.41$168K
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]879$32.60$29K
2026-03-05IONSIONIS PHARMACEUTICALS INCM — Option exercise [10b5-1]820$56.78$47K
2026-03-05IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]4.1K$79.36$325K
2026-02-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale5.3K$82.96$439K
2026-02-03IONSIONIS PHARMACEUTICALS INCA — Grant or award10.3K$0.00
2026-01-21IONSIONIS PHARMACEUTICALS INCS — Open-market sale1.1K$75.78$87K
2026-01-21IONSIONIS PHARMACEUTICALS INCM — Option exercise2.9K$0.00
2026-01-21IONSIONIS PHARMACEUTICALS INCS — Open-market sale6.9K$75.75$523K
2026-01-21IONSIONIS PHARMACEUTICALS INCM — Option exercise17.0K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Baroldi Joseph?

Joseph Baroldi is the Executive Vice President and Chief Business Officer at Ionis Pharmaceuticals, a leader in antisense technology for drug development. He has been involved in various roles within the company, contributing to its focus on innovative treatments for a range of diseases.…

How many SEC Form 4 filings has Baroldi Joseph submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Baroldi Joseph been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 16 open-market sales ($6.29M) across all tracked filings.

Where can I see all of Baroldi Joseph's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Baroldi Joseph profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.